Comparing Resources
Tip: You can share the address of this page to allow others to view your comparison
| Resource | Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021–2030 |
|---|---|
| Purpose | This article presents an analysis of the costs associated with vaccine products and the delivery systems needed to achieve the coverage targets set by the Immunization Agenda 2030 (IA2030). It aims to provide insights into the financial requirements for scaling up immunization efforts to meet global health goals. |
| Content | The resource contains a detailed breakdown of costs related to both vaccine product and immunization delivery costs, including cold chain logistics, health worker salaries, and operational costs. The study provides estimates of the financial investment needed to achieve the aspirational IA2030 coverage targets for different vaccines and regions. |
| Use | This article can be used by policymakers, global health organizations, and national immunization planners to understand the financial implications of meeting IA2030 coverage goals. It supports the development of cost-effective immunization strategies by identifying where the most significant investments are required and how resources can be allocated to maximize impact. |
| Contraints/Limitations | Any limitations present in the underlying data sources have also been reflected in this analysis. The cost estimates are based on available price and delivery cost data and future projections. Additionally, the study may not address context-specific factors, such as political landscape or local health system capacity, which can affect the real costs of immunization delivery. |
| Example criteria this resource could address | Estimating the financial resources needed to scale up immunization programs to meet IA2030 targets, identifying the cost drivers for immunization delivery and vaccine procurement, supporting budget planning and resource mobilization efforts for national and global immunization programs. |
| If available, notes on the development process | It draws on data and modeling outputs from international health organizations, national immunization programs, research institutions, and vaccine manufacturers to create a comprehensive cost analysis. |
| Additional Links | |
| Link to access the resource | index.php?option=com_content&view=article&catid=657&id=24087 |